Remodelin delays non‐small cell lung cancer progression by inhibiting NAT10 via the EMT pathway DOI
Quanwei Guo, Weijun Yu, Jianfeng Tan

et al.

Cancer Medicine, Journal Year: 2024, Volume and Issue: 13(11)

Published: June 1, 2024

Lung cancer remains the foremost reason of cancer-related mortality, with invasion and metastasis profoundly influencing patient prognosis. N-acetyltransferase 10 (NAT10) catalyzes exclusive N (4)-acetylcytidine (ac4C) modification in eukaryotic RNA. NAT10 dysregulation is linked to various diseases, yet its role non-small cell lung (NSCLC) unclear. Our study delves into clinical significance functional aspects NSCLC.

Language: Английский

CLIC3 interacts with NAT10 to inhibit N4-acetylcytidine modification of p21 mRNA and promote bladder cancer progression DOI Creative Commons

Yujun Shuai,

Hui Zhang, Changhao Liu

et al.

Cell Death and Disease, Journal Year: 2024, Volume and Issue: 15(1)

Published: Jan. 5, 2024

Abstract Chromatin accessibility plays important roles in revealing the regulatory networks of gene expression, while its application bladder cancer is yet to be fully elucidated. Chloride intracellular channel 3 (CLIC3) protein has been reported associated with progression some tumors, whereas specific mechanism CLIC3 tumor remains unclear. Here, we screened for key genes through identification transcription factor binding site clustered region (TFCR) on basis chromatin and TF motif. was identified by joint profiling data TCGA database. Clinically, expression significantly elevated negatively correlated patient survival. promoted proliferation cells reducing p21 vitro vivo. Mechanistically, interacted NAT10 inhibited function NAT10, resulting downregulation ac4C modification stability mRNA. Overall, these findings uncover an novel mRNA may act as a potential therapeutic target cancer.

Language: Английский

Citations

7

NAT10‐mediated mRNA N4‐acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression DOI Creative Commons
Cuicui Zhao, Xuan Sun, Jing Chen

et al.

Thoracic Cancer, Journal Year: 2024, Volume and Issue: 15(10), P. 820 - 829

Published: Feb. 26, 2024

N-acetyltransferase 10 (NAT10) serves as a critical enzyme in mediating the N4-acetylcytidine (ac4C) that ensures RNA stability and effective translation processes. The role of NAT10 driving advancement breast cancer remains uninvestigated.

Language: Английский

Citations

6

N-Acetyltransferase 10 represses Uqcr11 and Uqcrb independently of ac4C modification to promote heart regeneration DOI Creative Commons
Wenya Ma, Yanan Tian,

Leping Shi

et al.

Nature Communications, Journal Year: 2024, Volume and Issue: 15(1)

Published: March 8, 2024

Abstract Translational control is crucial for protein production in various biological contexts. Here, we use Ribo-seq and RNA-seq to show that genes related oxidative phosphorylation are translationally downregulated during heart regeneration. We find Nat10 regulates the expression of Uqcr11 Uqcrb mRNAs mouse human cardiomyocytes. In mice, overexpression cardiomyocytes promotes cardiac regeneration improves function after injury. Conversely, treating neonatal mice with Remodelin—a pharmacological inhibitor—or genetically removing from their both inhibit Mechanistically, suppresses independently its ac4C enzyme activity. This suppression weakens mitochondrial respiration enhances glycolytic capacity cardiomyocytes, leading metabolic reprogramming. also observe P7 male pig hearts compared P1 controls. The levels lower female failing than non-failing hearts. further identify specific binding regions Nat10, validate pro-proliferative effects derived embryonic stem cells. Our findings indicate an epigenetic regulator could potentially become a clinical target.

Language: Английский

Citations

6

N4-acetylcytidine modifies primary microRNAs for processing in cancer cells DOI Creative Commons
Hailong Zhang,

Runhui Lu,

Jiayi Huang

et al.

Cellular and Molecular Life Sciences, Journal Year: 2024, Volume and Issue: 81(1)

Published: Feb. 3, 2024

Abstract N4 acetylcytidine (ac4C) modification mainly occurs on tRNA, rRNA, and mRNA, playing an important role in the expression of genetic information. However, it is still unclear whether microRNAs have undergone ac4C their potential physiological pathological functions. In this study, we identified that NAT10/THUMPD1 acetylates primary (pri-miRNAs) with modification. Knockdown NAT10 suppresses augments levels mature miRNAs pri-miRNAs, respectively. Molecular mechanism studies found pri-miRNA promotes processing into precursor miRNA (pre-miRNA) by enhancing interaction DGCR8, thereby increasing biogenesis miRNA. attenuates oncogenic characters lung cancer cells regulating production cancers. Moreover, highly expressed various clinical cancers negatively correlated poor prognosis. Thus, our results reveal plays a crucial initiation progression modulating to affect production, which would provide attractive therapeutic strategy for

Language: Английский

Citations

5

Remodelin delays non‐small cell lung cancer progression by inhibiting NAT10 via the EMT pathway DOI
Quanwei Guo, Weijun Yu, Jianfeng Tan

et al.

Cancer Medicine, Journal Year: 2024, Volume and Issue: 13(11)

Published: June 1, 2024

Lung cancer remains the foremost reason of cancer-related mortality, with invasion and metastasis profoundly influencing patient prognosis. N-acetyltransferase 10 (NAT10) catalyzes exclusive N (4)-acetylcytidine (ac4C) modification in eukaryotic RNA. NAT10 dysregulation is linked to various diseases, yet its role non-small cell lung (NSCLC) unclear. Our study delves into clinical significance functional aspects NSCLC.

Language: Английский

Citations

5